Panel Discussion – Evaluating Combination Therapies to Maximise Anti-Tumour Immune Activity
Time: 4:00 pm
day: Day Two
• What is the ideal combination strategy for neoantigen vaccines?
• What are the best combination therapies that maximise T cell responses and efficacy?
• How to identify a clear biologic effect caused by combination
• Improving clinical efficacy through immunotherapy combinations